Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Hutt

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nursing New Zealand (Wellington, N.Z. : 1995)|October 7, 2004
Canterbury nurse to stand for district health boardV Hutt
Arzneimittel-Forschung|February 1, 1995
Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteersV Hutt, R Bonn, E Fritschi, et al.
ZFA. Zeitschrift Fur Allgemeinmedizin|July 20, 1981
[Alcohol and lipid metabolism]J G Wechsler, H U Klör, V Hutt, et al.
Artery|January 1, 1980
Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugsJ G Wechsler, V Hutt, H U Klör, et al.
Arzneimittel-Forschung|December 1, 1994
Bioequivalence evaluation of the metabolites 1,2 and 1,3-glyceryl dinitrate of two different glyceryl trinitrate patches after 12-h usage in healthy volunteersV Hutt, K Sauter, G Pabst, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 1, 1983
Three different methods for estimating high density lipoprotein cholesterolV Hutt, H U Klör, J G Wechsler, et al.
Arzneimittel-Forschung|January 1, 1983
[Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia]V Hutt, J G Wechsler, H U Klör, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|February 1, 1984
[Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals]V Hutt, H U Klör, J G Wechsler, et al.
Arzneimittel-Forschung|January 1, 1983
[Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]V Hutt, J G Wechsler, H U Klör, et al.
Artery|January 1, 1980
Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugsV Hutt, J G Wechsler, H U Klör, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nursing New Zealand (Wellington, N.Z. : 1995)|October 7, 2004
Canterbury nurse to stand for district health boardV Hutt
Arzneimittel-Forschung|February 1, 1995
Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteersV Hutt, R Bonn, E Fritschi, et al.
ZFA. Zeitschrift Fur Allgemeinmedizin|July 20, 1981
[Alcohol and lipid metabolism]J G Wechsler, H U Klör, V Hutt, et al.
Artery|January 1, 1980
Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugsJ G Wechsler, V Hutt, H U Klör, et al.
Arzneimittel-Forschung|December 1, 1994
Bioequivalence evaluation of the metabolites 1,2 and 1,3-glyceryl dinitrate of two different glyceryl trinitrate patches after 12-h usage in healthy volunteersV Hutt, K Sauter, G Pabst, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 1, 1983
Three different methods for estimating high density lipoprotein cholesterolV Hutt, H U Klör, J G Wechsler, et al.
Arzneimittel-Forschung|January 1, 1983
[Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia]V Hutt, J G Wechsler, H U Klör, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|February 1, 1984
[Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals]V Hutt, H U Klör, J G Wechsler, et al.
Arzneimittel-Forschung|January 1, 1983
[Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]V Hutt, J G Wechsler, H U Klör, et al.
Artery|January 1, 1980
Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugsV Hutt, J G Wechsler, H U Klör, et al.
Pageof 3